Optima delivers advanced aseptic filling, isolator containment, and freeze-drying systems — ensuring sterility, high yield, modular scalability, and seamless integration for pharma and biotech manufacturing.
Description
Turnkey Aseptic Excellence
Contact us for availability
Applications
Optima deliver turnkey systems for sterile pharmaceutical production across multiple critical operations:
Aseptic Filling: sterile filling of liquids, suspensions, and powders into vials, syringes, infusion bottles, and cartridges.
Isolator & Containment: barrier technologies and isolators to protect personnel, product, and environment, particularly for high-potency or biologic drugs
Freeze Drying / Lyophilization: modular and scalable freeze-dryers integrated into filling lines for stabilizing sensitive biologics and injectables.
Optima offers fully integrated systems combining these elements into single turnkey solutions—for example, vial filling lines with integrated isolators and freeze dryers. Optima Packaging+3Optima Packaging+3Optima Packaging+3
Key Features & Specifications
System Type
Key Features
Typical Specifications / Capabilities
Aseptic Filling Systems
Rotary, piston, or nest-based filling; minimal product loss (= 1 object per batch); integrated inspection & control; CSPE approach inclusion.
Throughput up to ~45,000 units/hour (volume up to 500 mL)
Isolator & Containment Modules
RABS and full isolator systems; decontamination (DECOpulse H2O2); modular barrier technology; glove ports and airlock systems
Integration with filling and freeze-drying lines; customizable containment levels (sterility, potency)
Freeze Dryers / Lyophilization Units
Modular, scalable designs (Compact, High-capacity, Dual-level configurations); automated loading/unloading; integration with filling and isolators
Plate surfaces from ~1 m² up to 40+ m²; ice capacities from ~10 kg to 800 kg; temperature range from –60 °C to +80 °C; modular scaling (LYO-C, LYO-S, LYO-D, LYO-SCALE)
Why Choose Optima
Unified Turnkey Systems: Expert integration of filling, containment, and freeze-drying under one engineering platform (CSPE).
High Yield & Low Loss: Systems engineered to minimize product loss to one object per batch.
Modular & Scalable: Systems can evolve from small- to large-scale capacity while keeping common architecture.
Containment & Safety: Advanced isolator technologies (RABS, full isolators) and decontamination ensure product, operator, and environmental safety.
Digital & Smart Features: Integration of digital tools (monitoring, diagnostics, changeover support) to maximize uptime and process control.
Proven Reputation & Support: Decades of experience in pharma engineering and turn-key delivery, backed by Optima’s global ecosystems and MPI’s regional support.
Targeted Segments
Pharmaceutical & Biotech Manufacturers – especially sterile injectables, biologics, vaccines
Contract Development & Manufacturing Organizations (CDMOs / CMOs) – requiring modular, flexible production systems
Cell & Gene Therapy Producers – for delicate biologic payloads needing containment and stabilization
Vaccine & Plasma Processing – where freeze-drying and low-loss aseptic filling are critical
Regulated Markets with high potency drugs needing containment solutions
.jpg)
Reach valuable industrial buyers in minutes
Promote key products & content
Drive cost effective & measurable sales
